Calcium sensitization involved in dexmedetomidine-induced contraction of isolated rat aorta

Canadian Journal of Physiology and Pharmacology

Volumn 89, Issue 9, 2011, Pages 681-689

  Kim, Jae Gak ^a   Sung, Hui Jin ^a   Ok, Seong Ho ^a   Kwon, Seong Chun ^b   Cheon, Kwang Seong ^a   Kim, Hye Jung ^c   Chang, Ki Churl ^c   Shin, Il Woo ^c   Lee, Heon Keun ^c   Chung, Young Kyun ^c   Sohn, Ju Tae ^c  

^a Gyeongsang National University   (South Korea)

^b Kwandong University College of Medicine   (South Korea)

^c Gyeongsang National University School of Medicine   (South Korea)

Author keywords

2B adrenoceptor; Aorta; Calcium sensitization; Contraction; Dexmedetomidine; Hypertension; Protein kinase C

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ALPHA 2 ADRENERGIC RECEPTOR; DEXMEDETOMIDINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; RAUWOLSCINE; RHO KINASE; VERAPAMIL; ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM; POTASSIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; AORTA CONSTRICTION; AORTA MEDIA; ARTICLE; ATTENUATION; CALCIUM CELL LEVEL; CARDIOVASCULAR EFFECT; CELL ISOLATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; DRUG MEGADOSE; HEART MUSCLE TENSION; IN VITRO STUDY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SENSITIZATION; VASCULAR ENDOTHELIUM; VASCULAR RING; WESTERN BLOTTING; AGONISTS; ANIMAL; AORTA; CELL MEMBRANE PERMEABILITY; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION; SPRAGUE DAWLEY RAT; VASCULAR SMOOTH MUSCLE;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANIMALS; AORTA; CALCIUM; CELL MEMBRANE PERMEABILITY; DEXMEDETOMIDINE; IN VITRO TECHNIQUES; MALE; MUSCLE, SMOOTH, VASCULAR; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; POTASSIUM CHLORIDE; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC; RHO-ASSOCIATED KINASES;

EID: 80051985094     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/y11-065     Document Type: Article

References (37)

1. Abdel-Latif, A.A. 2001. Cross talk between cyclic nucleotides and polyphosphoinositide hydrolysis, protein kinases, and contraction in smooth muscle. Exp. Biol. Med. (Maywood), 226(3): 153-163. PMID:11361033.
2. 2-adrenergic receptor-mediated contraction of vascular smooth muscle. Circ. Res. 72(4): 778-785. PMID:8095186.
3. 2+-dependent regulation of vascular tone. J. Anesth. 21(2): 220-231. doi:10.1007/s00540-006-0487-5. PMID:17458652.
4. 2+ sensitivity in vascular smooth muscle cells. J. Anesth. 21(2): 232-242. doi:10.1007/ s00540-006-0488-4. PMID:17458653.
5. Anttila, M., Penttila, J., Helminen, A., Vuorilehto, L., and Scheinin, H. 2003. Bioavailability of dexmedetomidine after extravascular doses in healthy subjects. Br. J. Clin. Pharmacol. 56(6): 691-693. doi:10.1046/j.1365-2125.2003.01944.x. PMID:14616431.
6. Bloor, B.C., Ward, D.S., Belleville, J.P., and Maze, M. 1992. Effects of intravenous dexmedetomidine in humans. II. hemodynamic changes. Anesthesiology, 77(6): 1134-1142. doi:10.1097/ 00000542-199212000-00014. PMID:1361311.
7. Carollo, D.S., Nossaman, B.D., and Ramadhyani, U. 2008. Dexmedetomidine: a reviewof clinical applications. Curr. Opin. Anaesthesiol. 21(4): 457-461. doi:10.1097/ACO.0b013e328305e3ef. PMID: 18660652.
8. 2-AR vasoreactivity in chronic NOS inhibition hypertension. Am. J. Physiol. Heart Circ. Physiol. 284(1): H309-H316. PMID:12388232.
9. 2-adrenoceptor-stimulated RhoA and Rho kinase in rat aorta. Am. J. Physiol. Heart Circ. Physiol. 283(4): H1361-H1369. PMID:12234786.
10. DalBó, S., Goulart, S., Horst, H., Pizzolatti, M.G., and Ribeiro-do-Valle, R.M. 2008. Activation of endothelial nitric oxide synthase by proanthocyanidin-rich fraction from croton celtidifolius (euphorbiaceae): involvement of extracellular calcium influx in rat thoracic aorta. J. Pharmacol. Sci. 107(2): 181-189. doi:10.1254/ jphs.FP0072385. PMID:18566521.
11. Ebert, T.J., Hall, J.E., Barney, J.A., Uhrich, T.D., and Colinco, M.D. 2000. The effects of increasing plasma concentrations of dexmedetomidine in human. Anesthesiology, 93(2): 382-394. doi:10.1097/00000542-200008000-00016. PMID:10910487.
12. Erkonen, G., Lamb, F., and Tobias, J.D. 2008. High-dose dexmedetomidine-induced hypertension in a child with traumatic brain injury. Neurocrit. Care, 9(3): 366-369. doi:10.1007/s12028-008-9102-y. PMID:18491236.
13. Guimarães, S., and Moura, D. 2001. Vascular adrenoceptors: an update. Pharmacol. Rev. 53(2): 319-356. PMID:11356987.
14. Hall, J.E., Uhrich, T.D., Barney, J.A., Arain, S.R., and Ebert, T.J. 2000. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth. Analg. 90(3): 699-705. doi:10.1097/00000539-200003000-00035. PMID:10702460.
15. 1-adrenergic antagonist actions of dexmedetomidine on human isolated endothelium-denuded gastroepiploic arteries. Anesth. Analg. 94(6): 1434-1440. PMID:12032002.
16. Institute for Laboratory Animal Research. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, D.C.
17. 2+ mobilization and sensitivity in vascular smooth muscle. Trends Pharmacol. Sci. 10(8): 320-325. doi:10.1016/ 0165-6147(89)90066-7. PMID:2686129.
18. Kim, H.J., Sohn, J.T., Jeong, Y.S., Cho, M.S., Kim, H.J., Chang, K. C., et al. 2009. Direct effect of dexmedetomidine on rat isolated aorta involves endothelial nitric oxide synthesis and activation of the lipoxygenase pathway. Clin. Exp. Pharmacol. Physiol. 36(4): 406-412. doi:10.1111/j.1440-1681.2008.05082.x. PMID:19018801.
19. Kim, W.S., Baek, S.H., Lee, S.K., Jeon, T.Y., Kim, H.Y., and Shin, S. W. 2011. Dexmedetomidine does not produce vasocontraction on human isolated gastroepiploic artery. Korean J. Anesthesiol. 60(6): 428-433. doi:10.4097/kjae.2011.60.6.428. PMID:21738846.
20. Kobayashi, T., Hayashi, Y., Taguchi, K., Matsumoto, T., and Kamata, K. 2006. ANG II enhances contractile responses via PI3-kinase p110d pathway in aortas from diabetic rats with systemic hyperinsulinemia. Am. J. Physiol. Heart Circ. Physiol. 291(2): H846-H853. doi:10.1152/ajpheart.01349.2005. PMID:16517941.
21. 2+ level and ionic currents in guinea-pig ileal smooth muscle. Korean J. Physiol. Pharmacol. 4(1): 33-40.
22. Lee, Y.R., Lee, C.K., Park, H.J., Kim, H., Kim, J., Kim, J., et al. 2006. c-Jun N-terminal kinase contributes to norepinephrineinduced contraction through phosphorylation of caldesmon in rat aortic smooth muscle. J. Pharmacol. Sci. 100(2): 119-125. doi:10. 1254/jphs.FP0050777. PMID:16474208.
23. Mason, K.P., Zurakowski, D., Zgleszewski, S., Prescilla, R., Fontaine, P.J., and Dinardo, J.A. 2010. Incidence and predictors of hypertension during high-dose dexmedetomidine sedation for pediatric MRI. Paediatr. Anaesth. 20(6): 516-523. doi:10.1111/j. 1460-9592.2010.03299.x. PMID:20412458.
24. Mita, M., Yanagihara, H., Hishinuma, S., Saito, M., and Walsh, M.P. 2002. Membrane depolarization-induced contraction of rat caudal arterial smooth muscle involves Rho-associated kinase. Biochem. J. 364(2): 431-440. doi:10.1042/BJ20020191. PMID:12023886.
25. Molin, J.C., and Bendhack, L.M. 2004. Clonidine induces rat aorta relaxation by nitric oxide-dependent and-independent mechanisms. Vascul. Pharmacol. 42(1): 1-6. doi:10.1016/j.vph.2004.11. 006. PMID:15664881.
26. 2-terminal kinase contributes to dexmedetomidine-induced contraction in isolated rat aortic smooth muscle. Yonsei Med. J. 52(3): 420-428. doi:10.3349/ymj.2011.52.3.420. PMID:21488184.
27. 2-adrenoceptors in human isolated subcutaneous resistance arteries. Br. J. Pharmacol. 115(8): 1463-1468. PMID:8564206.
28. 2-adrenoceptors. Eur. J. Pharmacol. 355(2-3): 275-279. doi:10. 1016/S0014-2999(98)00518-4. PMID:9760042.
29. Sakurai, Y., Obata, T., Odaka, A., Terui, K., Tamura, M., and Miyao, H. 2010. Buccal administration of dexmedetomidine as a preanesthetic in children. J. Anesth. 24(1): 49-53. doi:10.1007/ s00540-009-0863-z. PMID:20175284.
30. 2-adrenergic agonist medetomidine on systemic and coronary hemodynamics in conscious dogs. Anesthesiology, 75(3): 499-511. doi:10.1097/ 00000542-199109000-00018. PMID:1679615.
31. Seok, Y., Kim, J.I., Ito, M., Kureishi, Y., Nakano, T., Kim, S.O., et al. 2006. Heat shock-induced augmentation of vascular contractility is independent of Rho-kinase. Clin. Exp. Pharmacol. Physiol. 33(3): 264-268. doi:10.1111/j.1440-1681.2006.04356.x. PMID:16487272.
32. Shah, S., Sangari, T., Qasim, M., and Martin, T. 2008. Severe hypertension and bradycardia after dexmedetomidine for radiology sedation in a patient with acute transverse myelitis. Paediatr. Anaesth. 18(7): 681-682. doi:10.1111/j.1460-9592.2008.02521.x. PMID:18331550.
33. 2+ sensitization of arterial muscle. Am. J. Physiol. Cell Physiol. 285(6): C1377-C1385. PMID:12890649.
34. 2-adrenoceptor agonist. Eur. J. Pharmacol. 150(1-2): 9-14. doi:10.1016/0014-2999(88)90744-3. PMID: 2900154.
35. Yuen, V.M., Irwin, M.G., Hui, T.W., Yuen, M.K., and Lee, L.H. 2007. A double-blind crossover assessment of the sedative and analgesic effects of intranasal dexmedetomidine. Anesth. Analg. 105(2): 374-380. doi:10.1213/01.ane.0000269488.06546.7c. PMID:17646493.
36. Yuen, V.M., Hui, T.W., Irwin, M.G., and Yuen, M.K. 2008. A comparison of intranasal dexmedetomidine and oral midazolam for premedication in pediatric anesthesia: a double-blinded randomized controlled trial. Anesth. Analg. 106(6): 1715-1721. doi:10.1213/ane.0b013e31816c8929. PMID:18499600.
37. Zub, D., Berkenbosch, J.W., and Tobias, J.D. 2005. Preliminary experience with oral dexmedetomidine for procedural and anesthetic premedication. Paediatr. Anaesth. 15(11): 932-938. doi:10.1111/j.1460-9592.2005.01623.x. PMID:16238552.